<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&amp;id=15839069</title><link>https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&amp;id=15839069</link><description>Individual feed output.</description><lastBuildDate>Fri, 23 Jan 2026 11:03:01 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>JPMorgan upgrades consumer goods stock on confidence in second-half acceleration</title><link>https://www.cnbc.com/2026/01/23/jpmorgan-upgrades-consumer-goods-stock-citing-expected-2h-acceleration.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>JPMorgan sees shares of Procter &amp; Gamble rising 11% from current levels.</description><pubDate>Fri, 23 Jan 2026 13:32:30 GMT</pubDate></item><item><title>Roth says this biopharma stock has room to run on drug momentum, upcoming trial catalysts</title><link>https://www.cnbc.com/2026/01/23/roth-says-this-biopharma-stock-has-room-to-run-on-drug-momentum-upcoming-trial-catalysts.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Roth's $212 price target implies an additional upside of 32% for shares of Insmed, which have already rallied 160% in the last 12 months.</description><pubDate>Fri, 23 Jan 2026 13:09:06 GMT</pubDate></item><item><title>Intel’s earnings beat couldn’t offset a weaker-than-expected outlook. Here’s what analysts are saying</title><link>https://www.cnbc.com/2026/01/23/intels-earnings-beat-couldnt-offset-a-weaker-than-expected-outlook-heres-what-analysts-are-saying.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>For the most part, Wall Street analysts maintained a hold-equivalent rating on Intel after supply constraints weighed on the company's current-quarter...</description><pubDate>Fri, 23 Jan 2026 12:47:16 GMT</pubDate></item><item><title>Friday's big stock stories: What’s likely to move the market in the next trading session</title><link>https://www.cnbc.com/2026/01/22/fridays-big-stock-stories-whats-likely-to-move-the-market.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The three major averages jumped for a second consecutive session Thursday, with the Dow Industrials wiping out the week's losses.</description><pubDate>Thu, 22 Jan 2026 23:35:32 GMT</pubDate></item><item><title>Where this top Fidelity bond manager is investing for 2026</title><link>https://www.cnbc.com/2026/01/22/where-this-top-fidelity-bond-manager-is-investing-for-2026.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Celso Muñoz is among what Morningstar calls the "best-in-class" bond fund managers at Fidelity. Here is where he sees opportunity for income-oriented ...</description><pubDate>Thu, 22 Jan 2026 20:43:05 GMT</pubDate></item></channel></rss>